Indication

Type II Gaucher Disease

1 clinical trial

1 product

Clinical trial

An Exploratory Clinical Trial to Evaluate the Tolerability and Safety of VGN-R08b Via Intracerebroventricular Injection in Patients With Type II Gaucher Disease

Status: Recruiting, Estimated PCD: 2025-01-15

Product